Share Price and Basic Stock Data
Last Updated: January 23, 2026, 6:20 pm
| PEG Ratio | 0.00 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Elango Industries Ltd operates in the steel alloys and special steel segment, a sector characterized by fluctuating demand and high competition. The company reported a market capitalization of ₹3.91 Cr with its stock price at ₹10.2. Revenue trends exhibit significant volatility; sales were recorded at ₹0.00 Cr for multiple quarters, with a notable increase to ₹1.93 Cr in June 2023. However, subsequent quarters saw a decline, with sales dropping to ₹0.65 Cr in December 2023 and projected figures remaining low. Over the past decade, Elango’s annual sales peaked at ₹0.55 Cr in March 2022 but fell to ₹0.00 Cr in March 2023, before rebounding to ₹2.58 Cr in March 2024. This inconsistency raises concerns regarding the company’s ability to maintain stable revenue streams amidst fluctuating operational performance.
Profitability and Efficiency Metrics
Profitability metrics for Elango Industries reveal substantial challenges. The operating profit margin (OPM) stood at -33.33%, indicating a significant operational loss relative to revenues. The net profit margin also reflected a concerning trend, with a net profit of -₹0.15 Cr reported in the latest period. Return on equity (ROE) and return on capital employed (ROCE) were both recorded at 5.67%, which are below the typical sector standards, suggesting inefficiency in generating returns from shareholder equity and capital investments. The company’s cash conversion cycle was measured at 3.80 days, a relatively efficient figure compared to industry norms, which generally range from 30 to 60 days for similar businesses. However, the lack of profitability undermines the effectiveness of this efficiency metric.
Balance Sheet Strength and Financial Ratios
Elango Industries’ balance sheet presents a mixed picture of financial health. The company reported no borrowings, reflecting a conservative approach to debt management. However, reserves stood at -₹0.11 Cr, indicating a depletion of retained earnings which may limit future growth potential. The current ratio was recorded at 3.69, suggesting that the company possesses sufficient liquidity to cover short-term liabilities, which is favorable compared to the typical sector benchmark of 1.5. The price-to-book value ratio stood at 0.98x, indicating that the stock is trading at a slight discount to its book value, which may attract value-focused investors. However, the decline in net worth, as evidenced by a negative return on net worth of -5.74%, raises concerns about the long-term viability of the business.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Elango Industries indicates a stable yet cautious investor sentiment. Promoters hold 35.20% of the company, while public shareholders comprise 64.79%, reflecting a significant public interest in the firm. The total number of shareholders has fluctuated slightly, with a count of 8,621 reported in September 2025, down from 8,668 in December 2024. This marginal decline may indicate a lack of confidence among smaller investors, potentially due to the company’s inconsistent performance and profitability challenges. The absence of foreign institutional investors (FIIs) and domestic institutional investors (DIIs) further underscores a lack of institutional backing, which can affect stock liquidity and overall market perception. The capital structure’s reliance on public ownership may expose the company to volatility in stock prices, particularly in response to operational challenges.
Outlook, Risks, and Final Insight
The outlook for Elango Industries is contingent on its ability to stabilize revenue and improve profitability. Key strengths include its zero-debt position, which provides financial flexibility, and a relatively efficient cash conversion cycle. However, risks are pronounced, including negative profit margins and dwindling reserves that could impede growth. The company must address operational inefficiencies and enhance revenue generation to regain investor confidence. Future scenarios could involve a potential turnaround if operational strategies are effectively implemented, leading to improved sales and profitability. Conversely, continued losses may result in further erosion of shareholder value and could compel management to consider strategic alternatives, including restructuring or divestiture of non-core assets. Ultimately, the path forward hinges on decisive actions to rectify financial and operational shortcomings.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Elango Industries Ltd | 3.90 Cr. | 10.2 | 16.1/8.45 | 9.72 | 0.00 % | 5.67 % | 5.67 % | 10.0 | |
| Ashnisha Industries Ltd | 97.8 Cr. | 3.69 | 4.94/2.57 | 337 | 2.30 | 0.00 % | 1.23 % | 0.28 % | 1.00 |
| Usha Martin Ltd | 12,459 Cr. | 409 | 498/279 | 29.5 | 97.3 | 0.73 % | 18.8 % | 15.8 % | 1.00 |
| Shah Alloys Ltd | 124 Cr. | 62.5 | 83.8/43.3 | 5.18 | 0.00 % | 25.8 % | 1,108 % | 10.0 | |
| Mukand Ltd | 1,773 Cr. | 123 | 162/84.4 | 27.4 | 66.3 | 1.63 % | 9.91 % | 7.84 % | 10.0 |
| Industry Average | 18,963.50 Cr | 225.73 | 103.68 | 66.63 | 0.46% | 13.27% | 192.30% | 5.67 |
Quarterly Result
| Metric | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0.00 | 0.00 | 0.00 | 1.93 | 0.00 | 0.65 | 0.00 | 0.04 | 0.00 | 0.90 | 0.01 | 0.21 | 0.03 |
| Expenses | 0.03 | 0.04 | 0.04 | 1.93 | 0.04 | 0.67 | 0.08 | 0.13 | 0.03 | 0.93 | 0.06 | 0.26 | 0.04 |
| Operating Profit | -0.03 | -0.04 | -0.04 | 0.00 | -0.04 | -0.02 | -0.08 | -0.09 | -0.03 | -0.03 | -0.05 | -0.05 | -0.01 |
| OPM % | 0.00% | -3.08% | -225.00% | -3.33% | -500.00% | -23.81% | -33.33% | ||||||
| Other Income | 0.01 | 0.01 | 0.02 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation | 0.01 | 0.01 | 0.00 | 0.01 | 0.00 | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit before tax | -0.03 | -0.04 | -0.02 | 0.00 | -0.04 | -0.03 | -0.09 | -0.09 | -0.03 | -0.03 | -0.05 | -0.05 | -0.01 |
| Tax % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | |
| Net Profit | -0.03 | -0.04 | -0.03 | 0.00 | -0.04 | -0.02 | -0.08 | -0.10 | -0.03 | -0.03 | -0.06 | -0.05 | -0.01 |
| EPS in Rs | -0.08 | -0.10 | -0.08 | 0.00 | -0.10 | -0.05 | -0.21 | -0.26 | -0.08 | -0.08 | -0.16 | -0.13 | -0.03 |
Last Updated: December 27, 2025, 3:37 am
Below is a detailed analysis of the quarterly data for Elango Industries Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Sales, as of Sep 2025, the value is 0.03 Cr.. The value appears to be declining and may need further review. It has decreased from 0.21 Cr. (Jun 2025) to 0.03 Cr., marking a decrease of 0.18 Cr..
- For Expenses, as of Sep 2025, the value is 0.04 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 0.26 Cr. (Jun 2025) to 0.04 Cr., marking a decrease of 0.22 Cr..
- For Operating Profit, as of Sep 2025, the value is -0.01 Cr.. The value appears strong and on an upward trend. It has increased from -0.05 Cr. (Jun 2025) to -0.01 Cr., marking an increase of 0.04 Cr..
- For OPM %, as of Sep 2025, the value is -33.33%. The value appears to be declining and may need further review. It has decreased from -23.81% (Jun 2025) to -33.33%, marking a decrease of 9.52%.
- For Other Income, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 0.00 Cr..
- For Interest, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 0.00 Cr..
- For Depreciation, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 0.00 Cr..
- For Profit before tax, as of Sep 2025, the value is -0.01 Cr.. The value appears strong and on an upward trend. It has increased from -0.05 Cr. (Jun 2025) to -0.01 Cr., marking an increase of 0.04 Cr..
- For Tax %, as of Sep 2025, the value is 0.00%. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 0.00%.
- For Net Profit, as of Sep 2025, the value is -0.01 Cr.. The value appears strong and on an upward trend. It has increased from -0.05 Cr. (Jun 2025) to -0.01 Cr., marking an increase of 0.04 Cr..
- For EPS in Rs, as of Sep 2025, the value is -0.03. The value appears strong and on an upward trend. It has increased from -0.13 (Jun 2025) to -0.03, marking an increase of 0.10.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 3:48 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0.00 | 0.00 | 0.29 | 0.48 | 0.51 | 0.20 | 0.15 | 0.25 | 0.55 | 0.00 | 2.58 | 0.96 | 1.15 |
| Expenses | 0.24 | 0.75 | 0.30 | 0.27 | 0.59 | 0.43 | 0.11 | 0.31 | 1.08 | 0.17 | 2.71 | 1.16 | 1.29 |
| Operating Profit | -0.24 | -0.75 | -0.01 | 0.21 | -0.08 | -0.23 | 0.04 | -0.06 | -0.53 | -0.17 | -0.13 | -0.20 | -0.14 |
| OPM % | -3.45% | 43.75% | -15.69% | -115.00% | 26.67% | -24.00% | -96.36% | -5.04% | -20.83% | -12.17% | |||
| Other Income | 0.15 | 0.00 | 0.61 | 0.01 | 0.01 | 0.00 | 0.00 | 0.11 | 0.11 | 0.05 | 0.01 | 0.00 | 0.00 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation | 0.02 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.03 | 0.02 | 0.02 | 0.02 | 0.00 |
| Profit before tax | -0.11 | -0.75 | 0.60 | 0.22 | -0.07 | -0.23 | 0.04 | 0.05 | -0.45 | -0.14 | -0.14 | -0.22 | -0.14 |
| Tax % | 0.00% | 0.00% | 0.00% | 18.18% | 0.00% | 0.00% | 0.00% | 20.00% | 0.00% | 0.00% | 7.14% | 0.00% | |
| Net Profit | -0.10 | -0.75 | 0.60 | 0.18 | -0.07 | -0.23 | 0.04 | 0.04 | -0.45 | -0.15 | -0.14 | -0.22 | -0.15 |
| EPS in Rs | -0.26 | -1.97 | 1.57 | 0.47 | -0.18 | -0.60 | 0.10 | 0.10 | -1.18 | -0.39 | -0.37 | -0.58 | -0.40 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -650.00% | 180.00% | -70.00% | -138.89% | -228.57% | 117.39% | 0.00% | -1225.00% | 66.67% | 6.67% | -57.14% |
| Change in YoY Net Profit Growth (%) | 0.00% | 830.00% | -250.00% | -68.89% | -89.68% | 345.96% | -117.39% | -1225.00% | 1291.67% | -60.00% | -63.81% |
Elango Industries Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 45% |
| 3 Years: | 20% |
| TTM: | 62% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 5% |
| 5 Years: | % |
| 3 Years: | 15% |
| TTM: | 29% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 6% |
| 5 Years: | 33% |
| 3 Years: | 13% |
| 1 Year: | -15% |
| Return on Equity | |
|---|---|
| 10 Years: | -1% |
| 5 Years: | -4% |
| 3 Years: | -4% |
| Last Year: | -6% |
Last Updated: September 5, 2025, 3:21 pm
Balance Sheet
Last Updated: December 4, 2025, 2:48 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 3.82 | 3.82 | 3.82 | 3.82 | 3.82 | 3.82 | 3.82 | 3.82 | 3.82 | 3.82 | 3.82 | 3.82 | 3.82 |
| Reserves | 1.15 | 0.31 | 0.91 | 1.09 | 1.02 | 0.79 | 0.83 | 0.91 | 0.46 | 0.31 | 0.17 | -0.05 | -0.11 |
| Borrowings | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Liabilities | 0.06 | 0.06 | 0.07 | 0.07 | 0.13 | 0.04 | 0.04 | 0.10 | 0.07 | 2.40 | 0.74 | 0.94 | 1.04 |
| Total Liabilities | 5.03 | 4.19 | 4.80 | 4.98 | 4.97 | 4.65 | 4.69 | 4.83 | 4.35 | 6.53 | 4.73 | 4.71 | 4.75 |
| Fixed Assets | 0.09 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.06 | 0.03 | 0.14 | 0.12 | 0.11 | 0.10 |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 3.06 | 3.06 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Assets | 1.88 | 1.13 | 4.77 | 4.95 | 4.94 | 4.62 | 4.66 | 4.74 | 4.32 | 6.39 | 4.61 | 4.60 | 4.65 |
| Total Assets | 5.03 | 4.19 | 4.80 | 4.98 | 4.97 | 4.65 | 4.69 | 4.83 | 4.35 | 6.53 | 4.73 | 4.71 | 4.75 |
Below is a detailed analysis of the balance sheet data for Elango Industries Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 3.82 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 3.82 Cr..
- For Reserves, as of Sep 2025, the value is -0.11 Cr.. The value appears to be worsening (becoming more negative). It has deteriorated from -0.05 Cr. (Mar 2025) to -0.11 Cr., marking a decline of 0.06 Cr..
- For Borrowings, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. However, Reserves are negative, which is a major warning sign. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 1.04 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.94 Cr. (Mar 2025) to 1.04 Cr., marking an increase of 0.10 Cr..
- For Total Liabilities, as of Sep 2025, the value is 4.75 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 4.71 Cr. (Mar 2025) to 4.75 Cr., marking an increase of 0.04 Cr..
- For Fixed Assets, as of Sep 2025, the value is 0.10 Cr.. The value appears to be declining and may need further review. It has decreased from 0.11 Cr. (Mar 2025) to 0.10 Cr., marking a decrease of 0.01 Cr..
- For CWIP, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Investments, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Other Assets, as of Sep 2025, the value is 4.65 Cr.. The value appears strong and on an upward trend. It has increased from 4.60 Cr. (Mar 2025) to 4.65 Cr., marking an increase of 0.05 Cr..
- For Total Assets, as of Sep 2025, the value is 4.75 Cr.. The value appears strong and on an upward trend. It has increased from 4.71 Cr. (Mar 2025) to 4.75 Cr., marking an increase of 0.04 Cr..
However, the Borrowings (0.00 Cr.) are higher than the Reserves (-0.11 Cr.), which may signal higher financial risk.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -0.24 | -0.75 | -0.01 | 0.21 | -0.08 | -0.23 | 0.04 | -0.06 | -0.53 | -0.17 | -0.13 | -0.20 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 37.76 | 0.00 | 393.63 | 1,387.00 | 1,849.33 | 116.80 | 0.00 | 0.00 | 3.80 | |||
| Inventory Days | 0.00 | 0.00 | ||||||||||
| Days Payable | ||||||||||||
| Cash Conversion Cycle | 37.76 | 0.00 | 393.63 | 1,387.00 | 1,849.33 | 116.80 | 0.00 | 0.00 | 3.80 | |||
| Working Capital Days | 4,505.86 | -53.23 | 307.75 | 6,205.00 | 3,260.67 | 1,854.20 | 132.73 | 367.83 | 908.70 | |||
| ROCE % | -2.19% | -16.48% | 13.54% | 4.56% | -1.44% | -4.87% | 0.86% | 1.07% | -9.99% | -3.33% | -3.45% | -5.67% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | -0.57 | -0.38 | -0.40 | -1.18 | 0.11 |
| Diluted EPS (Rs.) | -0.57 | -0.38 | -0.40 | -1.18 | 0.11 |
| Cash EPS (Rs.) | -0.52 | -0.32 | -0.33 | -1.09 | 0.11 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 9.87 | 10.44 | 10.82 | 11.21 | 12.39 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 9.87 | 10.44 | 10.82 | 11.21 | 12.39 |
| Revenue From Operations / Share (Rs.) | 2.51 | 6.75 | 0.00 | 1.44 | 0.65 |
| PBDIT / Share (Rs.) | -0.51 | -0.30 | -0.32 | -1.10 | 0.14 |
| PBIT / Share (Rs.) | -0.55 | -0.36 | -0.38 | -1.19 | 0.14 |
| PBT / Share (Rs.) | -0.55 | -0.36 | -0.38 | -1.19 | 0.14 |
| Net Profit / Share (Rs.) | -0.56 | -0.37 | -0.39 | -1.18 | 0.11 |
| PBDIT Margin (%) | -20.58 | -4.52 | -6510.52 | -76.52 | 21.96 |
| PBIT Margin (%) | -22.25 | -5.33 | -7705.26 | -82.68 | 21.88 |
| PBT Margin (%) | -22.25 | -5.33 | -7705.26 | -82.68 | 21.88 |
| Net Profit Margin (%) | -22.61 | -5.61 | -7931.57 | -81.87 | 17.05 |
| Return on Networth / Equity (%) | -5.74 | -3.62 | -3.64 | -10.49 | 0.90 |
| Return on Capital Employeed (%) | -5.58 | -3.40 | -3.53 | -10.59 | 1.15 |
| Return On Assets (%) | -4.60 | -3.05 | -2.30 | -10.32 | 0.88 |
| Asset Turnover Ratio (%) | 0.20 | 0.45 | 0.00 | 0.11 | 0.05 |
| Current Ratio (X) | 3.69 | 4.73 | 2.09 | 44.05 | 15.06 |
| Quick Ratio (X) | 3.69 | 4.73 | 2.09 | 44.05 | 15.06 |
| Enterprise Value (Cr.) | 3.73 | 4.06 | 1.53 | 1.85 | 0.81 |
| EV / Net Operating Revenue (X) | 3.89 | 1.57 | 804.07 | 3.37 | 3.23 |
| EV / EBITDA (X) | -18.89 | -34.74 | -12.35 | -4.41 | 14.72 |
| MarketCap / Net Operating Revenue (X) | 3.89 | 1.57 | 1661.39 | 8.50 | 3.44 |
| Price / BV (X) | 0.98 | 1.02 | 0.76 | 1.09 | 0.18 |
| Price / Net Operating Revenue (X) | 3.89 | 1.57 | 2065.00 | 8.50 | 3.44 |
| EarningsYield | -0.05 | -0.03 | -0.04 | -0.09 | 0.04 |
After reviewing the key financial ratios for Elango Industries Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is -0.57. This value is below the healthy minimum of 5. It has decreased from -0.38 (Mar 24) to -0.57, marking a decrease of 0.19.
- For Diluted EPS (Rs.), as of Mar 25, the value is -0.57. This value is below the healthy minimum of 5. It has decreased from -0.38 (Mar 24) to -0.57, marking a decrease of 0.19.
- For Cash EPS (Rs.), as of Mar 25, the value is -0.52. This value is below the healthy minimum of 3. It has decreased from -0.32 (Mar 24) to -0.52, marking a decrease of 0.20.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 9.87. It has decreased from 10.44 (Mar 24) to 9.87, marking a decrease of 0.57.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 9.87. It has decreased from 10.44 (Mar 24) to 9.87, marking a decrease of 0.57.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 2.51. It has decreased from 6.75 (Mar 24) to 2.51, marking a decrease of 4.24.
- For PBDIT / Share (Rs.), as of Mar 25, the value is -0.51. This value is below the healthy minimum of 2. It has decreased from -0.30 (Mar 24) to -0.51, marking a decrease of 0.21.
- For PBIT / Share (Rs.), as of Mar 25, the value is -0.55. This value is below the healthy minimum of 0. It has decreased from -0.36 (Mar 24) to -0.55, marking a decrease of 0.19.
- For PBT / Share (Rs.), as of Mar 25, the value is -0.55. This value is below the healthy minimum of 0. It has decreased from -0.36 (Mar 24) to -0.55, marking a decrease of 0.19.
- For Net Profit / Share (Rs.), as of Mar 25, the value is -0.56. This value is below the healthy minimum of 2. It has decreased from -0.37 (Mar 24) to -0.56, marking a decrease of 0.19.
- For PBDIT Margin (%), as of Mar 25, the value is -20.58. This value is below the healthy minimum of 10. It has decreased from -4.52 (Mar 24) to -20.58, marking a decrease of 16.06.
- For PBIT Margin (%), as of Mar 25, the value is -22.25. This value is below the healthy minimum of 10. It has decreased from -5.33 (Mar 24) to -22.25, marking a decrease of 16.92.
- For PBT Margin (%), as of Mar 25, the value is -22.25. This value is below the healthy minimum of 10. It has decreased from -5.33 (Mar 24) to -22.25, marking a decrease of 16.92.
- For Net Profit Margin (%), as of Mar 25, the value is -22.61. This value is below the healthy minimum of 5. It has decreased from -5.61 (Mar 24) to -22.61, marking a decrease of 17.00.
- For Return on Networth / Equity (%), as of Mar 25, the value is -5.74. This value is below the healthy minimum of 15. It has decreased from -3.62 (Mar 24) to -5.74, marking a decrease of 2.12.
- For Return on Capital Employeed (%), as of Mar 25, the value is -5.58. This value is below the healthy minimum of 10. It has decreased from -3.40 (Mar 24) to -5.58, marking a decrease of 2.18.
- For Return On Assets (%), as of Mar 25, the value is -4.60. This value is below the healthy minimum of 5. It has decreased from -3.05 (Mar 24) to -4.60, marking a decrease of 1.55.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.20. It has decreased from 0.45 (Mar 24) to 0.20, marking a decrease of 0.25.
- For Current Ratio (X), as of Mar 25, the value is 3.69. This value exceeds the healthy maximum of 3. It has decreased from 4.73 (Mar 24) to 3.69, marking a decrease of 1.04.
- For Quick Ratio (X), as of Mar 25, the value is 3.69. This value exceeds the healthy maximum of 2. It has decreased from 4.73 (Mar 24) to 3.69, marking a decrease of 1.04.
- For Enterprise Value (Cr.), as of Mar 25, the value is 3.73. It has decreased from 4.06 (Mar 24) to 3.73, marking a decrease of 0.33.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 3.89. This value exceeds the healthy maximum of 3. It has increased from 1.57 (Mar 24) to 3.89, marking an increase of 2.32.
- For EV / EBITDA (X), as of Mar 25, the value is -18.89. This value is below the healthy minimum of 5. It has increased from -34.74 (Mar 24) to -18.89, marking an increase of 15.85.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 3.89. This value exceeds the healthy maximum of 3. It has increased from 1.57 (Mar 24) to 3.89, marking an increase of 2.32.
- For Price / BV (X), as of Mar 25, the value is 0.98. This value is below the healthy minimum of 1. It has decreased from 1.02 (Mar 24) to 0.98, marking a decrease of 0.04.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 3.89. This value exceeds the healthy maximum of 3. It has increased from 1.57 (Mar 24) to 3.89, marking an increase of 2.32.
- For EarningsYield, as of Mar 25, the value is -0.05. This value is below the healthy minimum of 5. It has decreased from -0.03 (Mar 24) to -0.05, marking a decrease of 0.02.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Elango Industries Ltd:
- Net Profit Margin: -22.61%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: -5.58% (Industry Average ROCE: 13.27%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: -5.74% (Industry Average ROE: 192.3%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 0
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 3.69
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 0 (Industry average Stock P/E: 103.68)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: -22.61%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Steel - Alloys/Special | No.5, Ranganathan Garden, 15th Main Road Extension, Chennai (Madras) Tamil Nadu 600040 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. S Elangovan | Managing Director |
| Mr. S A Premkumar | Director |
| Dr. M Ramasamy | Independent Director |
| Ms. Preethi Natarajan | Independent Director |
| Mrs. Asitha K | Independent Director |
FAQ
What is the intrinsic value of Elango Industries Ltd?
Elango Industries Ltd's intrinsic value (as of 26 January 2026) is ₹7.58 which is 25.69% lower the current market price of ₹10.20, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's ₹3.90 Cr. market cap, FY2025-2026 high/low of ₹16.1/8.45, reserves of ₹-0.11 Cr, and liabilities of ₹4.75 Cr.
What is the Market Cap of Elango Industries Ltd?
The Market Cap of Elango Industries Ltd is 3.90 Cr..
What is the current Stock Price of Elango Industries Ltd as on 26 January 2026?
The current stock price of Elango Industries Ltd as on 26 January 2026 is ₹10.2.
What is the High / Low of Elango Industries Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Elango Industries Ltd stocks is ₹16.1/8.45.
What is the Stock P/E of Elango Industries Ltd?
The Stock P/E of Elango Industries Ltd is .
What is the Book Value of Elango Industries Ltd?
The Book Value of Elango Industries Ltd is 9.72.
What is the Dividend Yield of Elango Industries Ltd?
The Dividend Yield of Elango Industries Ltd is 0.00 %.
What is the ROCE of Elango Industries Ltd?
The ROCE of Elango Industries Ltd is 5.67 %.
What is the ROE of Elango Industries Ltd?
The ROE of Elango Industries Ltd is 5.67 %.
What is the Face Value of Elango Industries Ltd?
The Face Value of Elango Industries Ltd is 10.0.